
Insider and congress filings
The Clorox Company (CLX)
NYSE · Consumer Defensive · 391 insider filings · 77 congress trades · last filed 2 months agoS&P 500
About The Clorox Company
from the company's filings and listing- Exchange
- NYSE
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Chief executive
- Linda J. Rendle
- Employees
- 9,200
- Listed since
- Mar 21, 1983
- Market value
- $10.8B
- Price to earnings
- 18.6
- Earnings per share
- $4.82
- Dividend yield
- 5.55%
Earnings
6 reported quarters · next on Nov 3, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q4 FY2026reported Aug 3, 2026 | $1.66 | $1.64 | $1.9B | $1.9B | EPS in lineRevenue beat |
| Q3 FY2026reported Apr 30, 2026 | $1.64 | $1.55 | $1.7B | $1.7B | EPS beatRevenue in line |
| Q2 FY2026reported Feb 3, 2026 | $1.39 | $1.43 | $1.7B | $1.6B | EPS missRevenue beat |
| Q1 FY2026reported Nov 3, 2025 | $0.85 | $0.82 | $1.4B | $1.4B | EPS beatRevenue beat |
| Q4 FY2025reported Jul 31, 2025 | $2.87 | $2.20 | $2.0B | $1.9B | EPS beatRevenue beat |
| Q3 FY2025reported May 5, 2025 | $1.45 | $1.55 | $1.7B | $1.7B | EPS missRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Oct 7, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Linda RendleChair and Chief Executive Officer (CEO) | $1.3M | $9.8M | $2.3M | $13.3M |
| Nina BartonEVP and Group President-Care & Connection | $646K | $8.0M | $1.4M | $10.1M |
| Eric ReynoldsEVP and Chief Operating & Strategy Officer | $807K | $3.0M | $956K | $4.8M |
| Chris HyderEVP and Group President-Health & Hygiene | $669K | $3.0M | $698K | $4.4M |
| Luc BelletEVP and Chief Financial Officer (CFO) | $515K | $1.6M | $508K | $2.6M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $958.6M | 10,044,423 | -1.3% | 8.25% |
| State Street Corp | $804.8M | 8,432,523 | +2.2% | 6.92% |
| Vanguard Capital Management LLC | $753.6M | 7,896,390 | +0.6% | 6.48% |
| Invesco Ltd. | $573.6M | 6,010,072 | +23.7% | 4.94% |
| Vanguard Portfolio Management LLC | $553.5M | 5,799,952 | +0.3% | 4.76% |
| Geode Capital Management, LLC | $310.4M | 3,265,551 | +1.1% | 2.68% |
| VAN Eck Associates Corp | $283.7M | 2,972,952 | -7.6% | 2.44% |
| Morgan Stanley | $214.4M | 2,246,813 | -17.3% | 1.85% |
| Millennium Management LLC | $197.8M | 2,073,010 | +199.6% | 1.70% |
| UBS Group AG | $189.0M | 1,980,435 | +116.6% | 1.63% |
| Bank Of America Corp | $179.8M | 1,883,700 | +34.0% | 1.55% |
| Citadel Advisors LLC | $168.5M | 1,765,044 | +23.7% | 1.45% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Open-market insider trades
2 filings of 391 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Pierre R. BreberDirector | Bought | 5,000 | $85.82 | $429K | May 5, 2026 | 0d |
| Pierre R. BreberDirector | Bought | 4,000 | $104.13 | $417K | Nov 21, 2025 | 3d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in CLX
20 disclosures of 77 on record · median 24d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | 0.0%S&P +0.4% · vs S&P 500 -0.4% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +2.9%S&P +5.8% · vs S&P 500 -2.9% | May 1, 2026 | Jun 9, 2026 | 39d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -0.9%S&P +3.2% · vs S&P 500 -4.1% | May 15, 2026 | Jun 8, 2026 | 24d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -18.3%S&P +9.8% · vs S&P 500 -28.1% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -8.8%S&P +11.7% · vs S&P 500 -20.5% | Dec 19, 2025 | Jan 12, 2026 | 24d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -14.4%S&P +11.6% · vs S&P 500 -26.0% | Nov 12, 2025 | Dec 15, 2025 | 33d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -14.4%S&P +11.9% · vs S&P 500 -26.3% | Nov 10, 2025 | Dec 8, 2025 | 28d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | -20.2%S&P +12.0% · vs S&P 500 -32.1% | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClain | Stock | Sale | $1,001 - $15,000 | n/a | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClain | Stock | Purchase | $1,001 - $15,000 | n/a | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -25.6%S&P +13.9% · vs S&P 500 -39.5% | Oct 7, 2025 | Nov 6, 2025 | 30d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -27.1%S&P +14.9% · vs S&P 500 -42.0% | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -23.8%S&P +18.2% · vs S&P 500 -42.0% | Aug 26, 2025 | Sep 9, 2025 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -27.8%S&P +20.8% · vs S&P 500 -48.6% | Aug 4, 2025 | Sep 9, 2025 | 36d |
| Lisa C. McClainSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | -26.4%S&P +25.5% · vs S&P 500 -51.9% | Jun 24, 2025 | Aug 13, 2025 | 50d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -31.1%S&P +29.7% · vs S&P 500 -60.9% | May 28, 2025 | Jun 10, 2025 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -34.1%S&P +43.1% · vs S&P 500 -77.2% | Apr 23, 2025 | May 12, 2025 | 19d |
| Jefferson Shreve | Stock | Sale | $15,001 - $50,000 | -36.6%S&P +42.9% · vs S&P 500 -79.5% | Apr 11, 2025 | May 8, 2025 | 27d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -44.1%S&P +27.6% · vs S&P 500 -71.6% | Jan 17, 2025 | Feb 6, 2025 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -46.5%S&P +30.2% · vs S&P 500 -76.7% | Nov 15, 2024 | Dec 5, 2024 | 20d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
3 members · estimate, as of Sep 10, 20263 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Harriet M. Hageman | Republican · House | $15,001 - $50,000 | 1.1% |
| Gary C. Peters | Democrat · Senate | $15,001 - $50,000 | 0.5% |
| Jimmy Patronis | Republican · House | $1,001 - $15,000 | 0.4% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Nina BartonEVP-Chief Growth & Strategy of | Tax withholding | 1,681 | Jul 22, 2026 |
| Chris T. HyderEVP-Chief Operating Officer | Tax withholding | 277 | Jul 15, 2026 |
| Christopher J. WilliamsDirector | Stock award | 288 | Jun 30, 2026 |
| Matthew J. ShattockDirector | Stock award | 550 | Jun 30, 2026 |
| Christopher J. WilliamsDirector | Stock award | 297 | May 8, 2026 |
| Russell J. WeinerDirector | Stock award | 354 | Jun 30, 2026 |
| Russell J. WeinerDirector | Stock award | 242 | May 8, 2026 |
| Stephanie PlainesDirector | Stock award | 288 | Jun 30, 2026 |
| Stephanie PlainesDirector | Stock award | 104 | May 8, 2026 |
| Pierre R. BreberDirector | Stock award | 42 | May 8, 2026 |
| Pierre R. BreberDirector | Stock award | 354 | Jun 30, 2026 |
| Matthew J. ShattockDirector | Stock award | 271 | May 8, 2026 |
| Angela C. HiltEVP - Chief Legal Officer | Stock award | 26,324 | Jun 17, 2026 |
| Chris T. HyderEVP-Chief Operating Officer | Stock award | 42,118 | Jun 17, 2026 |
| Luc BelletEVP - Chief Financial Officer | Stock award | 42,118 | Jun 17, 2026 |
| Kirsten MarrinerEVP - Chief Admin Officer | Stock award | 26,324 | Jun 17, 2026 |
| Luc BelletEVP - Chief Financial Officer | Tax withholding | 244 | Apr 1, 2026 |
| Pierre R. BreberDirector | Stock award | 326 | Mar 31, 2026 |
| Stephanie PlainesDirector | Stock award | 265 | Mar 31, 2026 |
| Pierre R. BreberDirector | Stock award | 27 | Feb 13, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling CLX?
Across the 2 most recent open-market filings shown here, 2 were purchases and 0 were sales.
Which members of Congress have traded CLX?
Ro Khanna, Gilbert Ray Cisneros, Jr., Lisa C. McClain, Jefferson Shreve disclosed CLX transactions in the filings shown here.
Which members of Congress hold CLX?
3 members of Congress report a position in CLX in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Harriet M. Hageman, Gary C. Peters and Jimmy Patronis. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is CLX in the S&P 500 or the Nasdaq 100?
The Clorox Company is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are CLX trades disclosed?
Insider filings on this page reached the public a median of 3 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
